Comment from the Arachnoidis Soceity for Awareness and Prevention submitted by Terri Anderson Drug Products That Present Demonstrable Difficulties for Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act; Request for Nominations

Comment from the Arachnoidis Society for Awareness and Prevention

• See Attached

• Public Submission
• Posted:
  03/07/2014
• ID:
  FDA-2013-N-1523-0007